A research group from the Graduate School of Medicine and iGCORE at Nagoya University in Japan, has discovered that using an antibiotic to target Fusobacterium reduced the formation of lesions associated with endometriosis, ...
Jun 14, 2023
0
20
The public is in favor of the development of bacteria-killing viruses as an alternative to antibiotics—and more efforts to educate will make them significantly more likely to use the treatment, a new study published in ...
May 22, 2023
0
57
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, ...
May 17, 2023
0
37
For immunocompetent adults with recurrent Clostridioides difficile infection (rCDI), fecal microbiota transplantation (FMT) yields a significant increase in resolution compared with alternative treatments, according to a ...
May 16, 2023
0
1
Post-traumatic stress disorder (PTSD) is a mental health condition triggered by a terrifying event. Its symptoms include flashbacks, nightmares, and severe anxiety. Most people experience PTSD at some point in their lives, ...
May 2, 2023
0
29
The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy (ICB). This is the main conclusion of a study recently published ...
Apr 14, 2023
0
54
Resistance to HER2-targeted therapies can be a problem when treating patients with HER2-positive (HER2+) breast cancer. Therefore, the identification of new therapies for this patient group is important. Researchers at the ...
Mar 14, 2023
0
26
Under-fire Dutch medical device maker Philips said Wednesday extensive testing on its recalled respirator devices showed they were "within safety limits" for use, but that a final verdict rests with global regulatory authorities.
Dec 21, 2022
0
2
It's tempting to follow the latest trend when it comes to health care, but for patients who live with heart failure, some alternative treatments could have serious consequences.
Dec 13, 2022
0
8
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4
